| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.59B | 37.10B | 30.26B | 43.15B | 35.87B | 39.33B |
| Gross Profit | 3.46B | 3.64B | 3.99B | 8.25B | 4.63B | 5.20B |
| EBITDA | 1.10B | 1.11B | 1.52B | 5.58B | 2.46B | 2.99B |
| Net Income | -299.00M | 1.57B | 560.00M | 4.37B | 1.18B | 2.77B |
Balance Sheet | ||||||
| Total Assets | 59.88B | 72.94B | 58.84B | 59.56B | 55.49B | 61.50B |
| Cash, Cash Equivalents and Short-Term Investments | 7.66B | 16.90B | 6.35B | 11.72B | 7.63B | 9.94B |
| Total Debt | 5.51B | 1.40B | 5.41B | 4.92B | 9.10B | 15.72B |
| Total Liabilities | 26.64B | 36.98B | 25.22B | 27.05B | 28.19B | 37.02B |
| Stockholders Equity | 33.23B | 35.95B | 33.61B | 32.50B | 27.29B | 24.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.95B | -5.77B | 8.51B | 5.29B | 12.12B |
| Operating Cash Flow | 0.00 | 15.63B | -4.86B | 8.93B | 5.92B | 12.95B |
| Investing Cash Flow | 0.00 | -558.00M | -576.00M | 2.58B | -652.00M | -4.03B |
| Financing Cash Flow | 0.00 | -4.33B | -14.00M | -4.62B | -8.26B | -6.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥64.91B | 11.99 | ― | 3.95% | 2.75% | 25.75% | |
79 Outperform | ¥283.58B | 9.26 | 8.91% | 3.85% | 5.98% | 39.06% | |
75 Outperform | ¥16.24B | 10.34 | ― | 2.02% | 22.62% | 180.38% | |
70 Outperform | ¥61.72B | 12.68 | 11.47% | 1.88% | -0.81% | 28.73% | |
68 Neutral | ¥47.63B | 4.08 | 16.07% | 1.07% | 3.77% | 81.76% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥72.28B | 15.17 | ― | 0.55% | 2.93% | 10.00% |